Indikationen und Ergebnisse der Radiojodtherapie beim differenzierten Schilddrüsenkarzinom

BACKGROUND: Malignant tumors of the thyroid gland are the most frequent malignant endocrine neoplasms, comprising approximately 1% of all malignant tumors. In recent years there has been a clear rise in the incidence of differentiated thyroid carcinomas (DTC), especially small papillary carcinomas. OBJECTIVE: Indications for and results of radioiodine treatment (RAI) of DTC. MATERIAL AND METHODS: A review of the current literature and guidelines of RAI in DTC was carried out. RESULTS: The use of RAI is the most important adjuvant treatment option for DTC and is generally well-tolerated. CONCLUSION: Due to the combination of surgery and RAI the DTC has a very good prognosis compared with other cancers, with an average survival rate of more than 90%.